Cite

HARVARD Citation

    Oh, M. et al. (2023). The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer. Expert review of pharmacoeconomics & outcomes research. pp. 317-325. [Online]. 
  
Back to record